Preparedness for Infectious Threats: Public–Private Partnership to Develop an Affordable Vaccine for an Emergent Threat: The Trivalent Neisseria meningitidis ACW135 Polysaccharide Vaccine
Christopher B. Nelson, PhD, MPH,
Maureen Birmingham, DVM, MPH,
Alejandro Costa, MSc,
Joelle Daviaud, PhD, DEA, PharmD,
William Perea, MD, MPH,
Marie-Paule Kieny, PhD and
Daniel Tarantola, MD
At the time this work was completed, Christopher B. Nelson, Maureen Birmingham, Alejandro Costa, Joelle Daviaud, and Daniel Tarantola were with the Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. William Perea is with the Department of Communicable Disease Surveillance and Response, World Health Organization, Geneva. Marie-Paule Kieny is with the Initiative for Vaccine Research, World Health Organization, Geneva.